ARCHIVES

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Schmidt Attempted To Answer Critics

October 1, 1976

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

RFAs For Extramural Construction, Mouse Facility Available

March 2, 1990

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

January 14, 1983

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990